Editorial
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 28, 2009; 15(48): 6017-6022
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6017
Figure 1
Figure 1 Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) pathogenesis.
Figure 2
Figure 2 Management flowchart for NAFLD/NASH treatment and prevention. Elf: Enhanced liver fibrosis; BMI-WC: Body mass index-waist circumference; LFTs: Liver function tests; MS: Metabolic syndrome; US: Ultrasonography.